Auteurs
Corpus
PubMed
Racine
Corpus
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration SRAS - Corpus (PubMed)

Index « Auteurs » - entrée « Dale L. Barnard »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dale Fisher < Dale L. Barnard < Dale L. Bernard  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000B76 (2017) Yohichi Kumaki ; Andres M. Salazar ; Miles K. Wandersee ; Dale L. BarnardProphylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model.
001275 (2012) Andreas J. Kesel ; Hans-Christoph Weiss ; Andreas Schönleber ; Craig W. Day ; Dale L. Barnard ; Mervi A. Detorio ; Raymond F. SchinaziAntiviral agents derived from novel 1-adamantyl singlet nitrenes.
001494 (2011) Dale L. Barnard ; Yohichi KumakiRecent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.
001496 (2011) Ye V. Liu ; Michael J. Massare ; Dale L. Barnard ; Thomas Kort ; Margret Nathan ; Lei Wang ; Gale SmithChimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
001545 (2011) Yohichi Kumaki ; Miles K. Wandersee ; Aaron J. Smith ; Yanchen Zhou ; Graham Simmons ; Nathan M. Nelson ; Kevin W. Bailey ; Zachary G. Vest ; Joseph K-K Li ; Paul Kay-Sheung Chan ; Donald F. Smee ; Dale L. BarnardInhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.
001584 (2011) Yohichi Kumaki ; Jane Ennis ; Ramtin Rahbar ; Jeffrey D. Turner ; Miles K. Wandersee ; Aaron J. Smith ; Kevin W. Bailey ; Zachary G. Vest ; Jason R. Madsen ; Joseph K-K Li ; Dale L. BarnardSingle-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model.
001643 (2010) Cheng-Wei Yang ; Yue-Zhi Lee ; Iou-Jiun Kang ; Dale L. Barnard ; Jia-Tsrong Jan ; Du Lin ; Chun-Wei Huang ; Teng-Kuang Yeh ; Yu-Sheng Chao ; Shiow-Ju LeeIdentification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus.
001732 (2010) Yohichi Kumaki ; Craig W. Day ; Kevin W. Bailey ; Miles K. Wandersee ; Min-Hui Wong ; Jason R. Madsen ; Justin S. Madsen ; Nathan M. Nelson ; Justin D. Hoopes ; John D. Woolcott ; Tyler Z. Mclean ; Lawrence M. Blatt ; Andres M. Salazar ; Donald F. Smee ; Dale L. BarnardInduction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice.
001777 (2010) Barry R. O'Keefe ; Barbara Giomarelli ; Dale L. Barnard ; Shilpa R. Shenoy ; Paul K S. Chan ; James B. Mcmahon ; Kenneth E. Palmer ; Brian W. Barnett ; David K. Meyerholz ; Christine L. Wohlford-Lenane ; Paul B. MccrayBroad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.
001810 (2009) Craig W. Day ; Ralph Baric ; Sui Xiong Cai ; Matt Frieman ; Yohichi Kumaki ; John D. Morrey ; Donald F. Smee ; Dale L. BarnardA new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.
001826 (2009) James A. Wiley ; Laura E. Richert ; Steve D. Swain ; Ann Harmsen ; Dale L. Barnard ; Troy D. Randall ; Mark Jutila ; Trevor Douglas ; Chris Broomell ; Mark Young ; Allen HarmsenInducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses.
001B21 (2008) G Mani Subramanian ; Paul A. Moore ; Brian B. Gowen ; Aaron L. Olsen ; Dale L. Barnard ; Jason Paragas ; Robert J. Hogan ; Robert W. SidwellPotent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
001B64 (2008) Dale L. Barnard ; Craig W. Day ; Kevin Bailey ; Matthew Heiner ; Robert Montgomery ; Larry Lauridsen ; Kie-Hoon Jung ; Joseph K-K Li ; Paul K S. Chan ; Robert W. SidwellIs the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model.
001B72 (2008) Yohichi Kumaki ; Craig W. Day ; Miles K. Wandersee ; Bradley P. Schow ; Justin S. Madsen ; Dixon Grant ; Jason P. Roth ; Donald F. Smee ; Lawrence M. Blatt ; Dale L. BarnardInterferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells.
001D64 (2007) Mary C. Hu ; Taff Jones ; Richard T. Kenney ; Dale L. Barnard ; David S. Burt ; George H. LowellIntranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice.
001F49 (2006) Chung K. Chu ; Srinivas Gadthula ; Xin Chen ; Hyunah Choo ; Sureyya Olgen ; Dale L. Barnard ; Robert W. SidwellAntiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).
001F50 (2006) Dale L. Barnard ; Craig W. Day ; Kevin Bailey ; Matthew Heiner ; Robert Montgomery ; Larry Lauridsen ; Paul K S. Chan ; Robert W. SidwellEvaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.
002271 (2006) Dale L. Barnard ; Craig W. Day ; Kevin Bailey ; Matthew Heiner ; Robert Montgomery ; Larry Lauridsen ; Scott Winslow ; Justin Hoopes ; Joseph K-K Li ; Jongdae Lee ; Dennis A. Carson ; Howard B. Cottam ; Robert W. SidwellEnhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
002B28 (2004) Dale L. BarnardAmerican Society for Virology-23rd annual meeting. Vaccines and antiviral agents 10-14 July 2004, Montreal Canada.
002E61 (2004) Dale L. Barnard ; Valerie D. Hubbard ; Jared Burton ; Donald F. Smee ; John D. Morrey ; Michael J. Otto ; Robert W. SidwellInhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i -k "Dale L. Barnard" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i  \
                -Sk "Dale L. Barnard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    Dale L. Barnard
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021